Day One Biopharmaceuticals, Inc.
DAWNCIK 0001845337 · Every Form 4 filed by insiders at this issuer.
Filings
13
Latest Mar 26, 2024
Unique insiders
6
Showing
13 of 13
Page 1
Top insiders
Most active reporters at Day One Biopharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| Blackman Samuel C. | Officer | 5 |
| Bender Jeremy | OfficerDirector | 2 |
| Dubow Adam | Officer | 2 |
| York Charles N II | Officer | 2 |
| Dable Habib J | Director | 1 |
| Grossman William | Director | 1 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 26, 2024 | Blackman Samuel C. HEAD OF R&D | S | 10,000 | $16.0055 | $160,055 | |
| Mar 13, 2024 | Blackman Samuel C. HEAD OF R&D | S | 30,000 | $15.2438 | $457,314 | |
| Feb 28, 2024 | Blackman Samuel C. HEAD OF R&D | S | 20,000 | $16.1083 | $322,166 | |
| Feb 20, 2024 | Bender Jeremy CHIEF EXECUTIVE OFFICER · Director | S | 7,615 | $15.2481 | $116,114 | |
| Feb 20, 2024 | Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME | S | 2,258 | $15.2481 | $34,430 | |
| Feb 20, 2024 | York Charles N II COO, CFO AND SECRETARY | S | 2,666 | $15.2481 | $40,651 | |
| Feb 20, 2024 | Dubow Adam GENERAL COUNSEL | S | 3,242 | $15.2481 | $49,434 | |
| Jan 19, 2024 | Dable Habib J Director | Holdings only | — | — | — | |
| Jan 19, 2024 | Grossman William Director | Holdings only | — | — | — | |
| Jan 9, 2024 | Bender Jeremy Chief Executive Officer · Director | Holdings only | — | — | — | |
| Jan 9, 2024 | Blackman Samuel C. Head of Research and Developme | Holdings only | — | — | — | |
| Jan 9, 2024 | Dubow Adam General Counsel | Holdings only | — | — | — | |
| Jan 9, 2024 | York Charles N II COO, CFO and Secretary | Holdings only | — | — | — |
Showing 1–13 of 13
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.